why choose us

First received: October 30, 2024

Clinical Trial: MxA-Guided Antiviral Treatment in Respiratory Viral Infections

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Respiratory Viral Infections

Study Type: INTERVENTIONAL


Official Title: Application of Myxovirus Resistance Protein A in Antiviral Treatment Guidance of Respiratory Viral Infections

Brief Summary: This pilot randomized controlled trial (RCT) will investigate the clinical impact of Myxovirus Resistance Protein A (MxA)-guided antiviral treatment versus standard treatment in patients with respiratory viral infections.

Read more